2024
Warren, M., Barrett, A., Bhalla, N., Brada, M., Chuter, R., Cobben, D., . . . Fenwick, J. D. (2024). Sorting lung tumor volumes from 4D-MRI data using an automatic tumor-based signal reduces stitching artifacts.. Journal of applied clinical medical physics, e14262. doi:10.1002/acm2.14262DOI: 10.1002/acm2.14262
2023
Warren, M., Barrett, A., Bhalla, N., Brada, M., Cobben, D., McClelland, J., . . . Fenwick, J. (2023). OC-0779 Reconstruction of lung tumour volumes from 4D-MRI: the use of a tumour-derived respiratory signal. Radiotherapy and Oncology, 182, S648-S650. doi:10.1016/s0167-8140(23)08720-0DOI: 10.1016/s0167-8140(23)08720-0
2022
Brada, M., Forbes, H., Ashley, S., & Fenwick, J. (2022). Robust Comprehensive Dataset Provides Pause for Thought. JOURNAL OF THORACIC ONCOLOGY, 17(6), E56-E57. doi:10.1016/j.jtho.2022.03.017DOI: 10.1016/j.jtho.2022.03.017
Brada, M., Forbes, H., Ashley, S., & Fenwick, J. (2022). Improving Outcomes in NSCLC: Optimum Dose Fractionation in Radical Radiotherapy Matters.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 17(4), 532-543. doi:10.1016/j.jtho.2022.01.006DOI: 10.1016/j.jtho.2022.01.006
2021
Saran, F., Welsh, L., James, A., McBain, C., Gattamaneni, R., Jefferies, S., . . . Brada, M. (2021). Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial. JOURNAL OF NEURO-ONCOLOGY, 155(3), 307-317. doi:10.1007/s11060-021-03877-6DOI: 10.1007/s11060-021-03877-6
Turtle, L., Bhalla, N., Willett, A., Biggar, R., Leadbetter, J., Georgiou, G., . . . Fenwick, J. D. (2021). Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer. RADIATION ONCOLOGY, 16(1). doi:10.1186/s13014-021-01824-3DOI: 10.1186/s13014-021-01824-3
ESTRO ACROP guideline for target volume delineation of skull base tumors (Journal article)
Combs, S. E., Baumert, B. G., Bendszus, M., Bozzao, A., Brada, M., Fariselli, L., . . . Minniti, G. (2021). ESTRO ACROP guideline for target volume delineation of skull base tumors. RADIOTHERAPY AND ONCOLOGY, 156, 80-94. doi:10.1016/j.radonc.2020.11.014DOI: 10.1016/j.radonc.2020.11.014
2020
Sardaro, A., McDonald, F., Bardoscia, L., Lavrenkov, K., Singh, S., Ashley, S., . . . Brada, M. (2020). Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study. FRONTIERS IN ONCOLOGY, 10. doi:10.3389/fonc.2020.594590DOI: 10.3389/fonc.2020.594590
2019
Rosenfelder, N., & Brada, M. (2019). Integrated treatment of brain metastases. CURRENT OPINION IN ONCOLOGY, 31(6), 501-507. doi:10.1097/CCO.0000000000000573DOI: 10.1097/CCO.0000000000000573
Feasibility of cardiac sparing in isotoxic dose escalated radiotherapy for NSCLC (Conference Paper)
Turtle, L., Willett, A., Leadbetter, J., Brada, M., & Fenwick, J. (2019). Feasibility of cardiac sparing in isotoxic dose escalated radiotherapy for NSCLC. In RADIOTHERAPY AND ONCOLOGY Vol. 133 (pp. S157). doi:10.1016/S0167-8140(19)30727-3DOI: 10.1016/S0167-8140(19)30727-3
Improving outcomes in non-small cell lung cancer; population analysis of radical radiotherapy (Journal article)
Brada, M., Ball, C., Mitchell, S., Forbes, H., & Ashley, S. (2019). Improving outcomes in non-small cell lung cancer; population analysis of radical radiotherapy. RADIOTHERAPY AND ONCOLOGY, 132, 204-210. doi:10.1016/j.radonc.2018.10.015DOI: 10.1016/j.radonc.2018.10.015
Incidence and evolution of imaging changes on cone-beam CT during and after radical radiotherapy for non-small cell lung cancer (Journal article)
Clarke, E., Curtis, J., & Brada, M. (2019). Incidence and evolution of imaging changes on cone-beam CT during and after radical radiotherapy for non-small cell lung cancer. Radiotherapy and Oncology.
2018
Nurse-Led Telehealth Clinic in Treatment Monitoring and Follow Up (Conference Paper)
Cubbin, S., & Brada, M. (2018). Nurse-Led Telehealth Clinic in Treatment Monitoring and Follow Up. In JOURNAL OF THORACIC ONCOLOGY Vol. 13 (pp. S416-S417). doi:10.1016/j.jtho.2018.08.461DOI: 10.1016/j.jtho.2018.08.461
Basu, B., Krebs, M. G., Sundar, R., Wilson, R. H., Spicer, J., Jones, R., . . . Banerji, U. (2018). Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer. ANNALS OF ONCOLOGY, 29(9), 1918-1925. doi:10.1093/annonc/mdy245DOI: 10.1093/annonc/mdy245
Phase I study of afatinib and radiotherapy (RT) with or without temozolomide (TMZ) in newly diagnosed glioblastoma (GB). (Conference Paper)
Saran, F., Welsh, L., James, A., McBain, C., Gattamaneni, R., Jefferies, S., . . . Brada, M. (2018). Phase I study of afatinib and radiotherapy (RT) with or without temozolomide (TMZ) in newly diagnosed glioblastoma (GB).. In JOURNAL OF CLINICAL ONCOLOGY Vol. 36. doi:10.1200/JCO.2018.36.15_suppl.2036DOI: 10.1200/JCO.2018.36.15_suppl.2036
Bhalla, N., Brooker, R., & Brada, M. (2018). Combining immunotherapy and radiotherapy in lung cancer. Journal of Thoracic Disease, 10, S1447-S1460. doi:10.21037/jtd.2018.05.107DOI: 10.21037/jtd.2018.05.107
A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) (Conference Paper)
Saran, F., James, A., McBain, C., Jefferies, S., Harris, F., Cseh, A., . . . Brada, M. (2018). A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM). In NEURO-ONCOLOGY Vol. 20 (pp. 20). Retrieved from https://www.webofscience.com/
2017
TAX-TORC: A phase I trial of vistusertib (AZD2O14) in combination with weekly paclitaxel with integrated pharmacodynamic (PD) and molecular characterization (MC) studies. (Conference Paper)
Sundar, R., Basu, B., Wilson, R. H., Spicer, J. F., Jones, R. H., Krebs, M., . . . Banerji, U. (2017). TAX-TORC: A phase I trial of vistusertib (AZD2O14) in combination with weekly paclitaxel with integrated pharmacodynamic (PD) and molecular characterization (MC) studies.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 35. doi:10.1200/JCO.2017.35.15_suppl.2571DOI: 10.1200/JCO.2017.35.15_suppl.2571
Soffietti, R., Abacioglu, U., Baumert, B., Combs, S. E., Kinhult, S., Kros, J. M., . . . Weller, M. (2017). Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). NEURO-ONCOLOGY, 19(2), 162-174. doi:10.1093/neuonc/now241DOI: 10.1093/neuonc/now241
TAX-TORC: The Novel Combination of Weekly Paclitaxel and the Dual mTORC1/2 Inhibitor AZD2014 for the Treatment of Squamous NSCLC (Conference Paper)
Krebs, M., Spicer, J., Steele, N., Talbot, D., Brada, M., Wilson, R., . . . Yap, T. (2017). TAX-TORC: The Novel Combination of Weekly Paclitaxel and the Dual mTORC1/2 Inhibitor AZD2014 for the Treatment of Squamous NSCLC. In JOURNAL OF THORACIC ONCOLOGY Vol. 12 (pp. S1272-S1273). doi:10.1016/j.jtho.2016.11.1798DOI: 10.1016/j.jtho.2016.11.1798
2016
Brain metastases (Chapter)
Jyoti, B., Balkhi Alam, F., Hofer, S., & Brada, M. (2016). Brain metastases. In Unknown Book (pp. 589-592). Wiley. doi:10.1002/9781118777329.ch144DOI: 10.1002/9781118777329.ch144
Precision oncology: origins, optimism, and potential (Journal article)
Prasad, V., Fojo, T., & Brada, M. (2016). Precision oncology: origins, optimism, and potential. LANCET ONCOLOGY, 17(2), E81-E86. doi:10.1016/S1470-2045(15)00620-8DOI: 10.1016/S1470-2045(15)00620-8
ESTRO-ACROP guideline "target delineation of glioblastomas" (Journal article)
Niyazi, M., Brada, M., Chalmers, A. J., Combs, S. E., Erridge, S. C., Fiorentino, A., . . . Belka, C. (2016). ESTRO-ACROP guideline "target delineation of glioblastomas". RADIOTHERAPY AND ONCOLOGY, 118(1), 35-42. doi:10.1016/j.radonc.2015.12.003DOI: 10.1016/j.radonc.2015.12.003
2015
Glioma (Journal article)
Weller, M., Wick, W., Aldape, K., Brada, M., Berger, M., Pfister, S. M., . . . Reifenberger, G. (2015). Glioma. NATURE REVIEWS DISEASE PRIMERS, 1. doi:10.1038/nrdp.2015.17DOI: 10.1038/nrdp.2015.17
SABR in NSCLC - The beginning of the end or the end of the beginning? (Journal article)
Brada, M., Pope, A., & Baumann, M. (2015). SABR in NSCLC - The beginning of the end or the end of the beginning?. RADIOTHERAPY AND ONCOLOGY, 114(2), 135-137. doi:10.1016/j.radonc.2015.01.012DOI: 10.1016/j.radonc.2015.01.012
Against the motion (Conference Paper)
Brada, M. (2015). Against the motion. In RADIOTHERAPY AND ONCOLOGY Vol. 115 (pp. S169). Retrieved from https://www.webofscience.com/
New Developments in Intracranial Stereotactic Radiotherapy for Metastases (Journal article)
Pinkham, M. B., Whitfield, G. A., & Brada, M. (2015). New Developments in Intracranial Stereotactic Radiotherapy for Metastases. CLINICAL ONCOLOGY, 27(5), 316-323. doi:10.1016/j.clon.2015.01.007DOI: 10.1016/j.clon.2015.01.007
The definition of an auditable and complete dataset for lung cancer patients - the RTTis role (Conference Paper)
Blair, D., Brada, M., Clarke, E., Baker, C. R., Reilly, A. J., & Baker, A. F. (2015). The definition of an auditable and complete dataset for lung cancer patients - the RTTis role. In RADIOTHERAPY AND ONCOLOGY Vol. 115 (pp. S716-S717). Retrieved from https://www.webofscience.com/
2014
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Journal article)
Stupp, R., Brada, M., van den Bent, M. J., Tonn, J. -C., Pentheroudakis, G., & ESMO, G. W. G. (2014). High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ANNALS OF ONCOLOGY, 25, 93-101. doi:10.1093/annonc/mdu050DOI: 10.1093/annonc/mdu050
Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial (Journal article)
Collins, V. P., Ichimura, K., Di, Y., Pearson, D., Chan, R., Thompson, L. C., . . . Collaborators, B. (2014). Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2. doi:10.1186/2051-5960-2-68DOI: 10.1186/2051-5960-2-68
Pituitary radiotherapy (Chapter)
Ajithkumar, T., & Brada, M. (2014). Pituitary radiotherapy. In Endocrinology in Clinical Practice, Second Edition (pp. 85-102).
Cone beam CT verification for active breathing control (ABC)-gated radiotherapy for lung cancer (Journal article)
Yeoh, K. -W., McNair, H. A., McDonald, F., Hawkins, M., Hansen, V. N., Ramos, M., . . . Brada, M. (2014). Cone beam CT verification for active breathing control (ABC)-gated radiotherapy for lung cancer. ACTA ONCOLOGICA, 53(5), 716-719. doi:10.3109/0284186X.2013.861610DOI: 10.3109/0284186X.2013.861610
Is current technology improving outcomes with radiation therapy for gliomas? (Journal article)
Brada, M., & Haylock, B. (2014). Is current technology improving outcomes with radiation therapy for gliomas?. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, e89-e94. doi:10.14694/edbook_am.2014.34.e89DOI: 10.14694/edbook_am.2014.34.e89
Position statement on ethics, equipoise and research on charged particle radiation therapy (Journal article)
Sheehan, M., Timlin, C., Peach, K., Binik, A., Puthenparampil, W., Lodge, M., . . . Weijer, C. (2014). Position statement on ethics, equipoise and research on charged particle radiation therapy. JOURNAL OF MEDICAL ETHICS, 40(8), 572-575. doi:10.1136/medethics-2012-101290DOI: 10.1136/medethics-2012-101290
The legend of cytomegalovirus and glioblastoma lives on (Journal article)
Weller, M., Soffietti, R., & Brada, M. (2014). The legend of cytomegalovirus and glioblastoma lives on. NEURO-ONCOLOGY, 16(1), 166. doi:10.1093/neuonc/not204DOI: 10.1093/neuonc/not204
